MYC and acute myeloid leukemia: Notably, the synthetic naphthalene-based KIX domain inhibitor naphthol AS-E phosphate was the first small-molecule amide compound identified as a direct MYB-p300 inhibitor in MYC-driven AML cell lines [Figure 9][240].